Thermo Fisher Scientific (TMO) Payables (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Payables for 18 consecutive years, with $3.3 billion the latest figure, recorded in Q1 2026.

• Payables for Q1 2026 came in at $3.3 billion, up 9.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 billion (up 9.68% YoY), and the FY2025 annual result was $3.6 billion, up 17.64% from the prior year.
• Payables was $3.3 billion for Q1 2026 at Thermo Fisher Scientific, down from $3.6 billion in the prior quarter.
• Over five years, Payables peaked at $3.6 billion in Q4 2025 and troughed at $2.4 billion in Q3 2023.
• Average Payables over 5 years is $2.9 billion, with a median of $2.8 billion recorded in 2023.
• Year-over-year, Payables climbed 24.28% in 2022 and decreased 15.05% in 2023.
• Over 5 years, Payables stood at $3.4 billion in 2022, then fell by 15.05% to $2.9 billion in 2023, then rose by 7.21% to $3.1 billion in 2024, then rose by 17.64% to $3.6 billion in 2025, then slipped by 7.68% to $3.3 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.3 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.1 billion in Q3 2025.